Summary

  • Rocket Lab had issued about 29.3 million shares and raised roughly US$1.944 billion gross through its ATM programme by 15 September. Dilution has happened; the precise net cash after commissions and expenses is lower and was not specified in the filing.
  • Iridium's US$1.775 billion existing term loan can survive the acquisition under a lender consent. Rocket Lab's US$3.6 billion bridge commitment ended on 15 September, while shareholder and regulatory decisions still govern whether the acquisition closes.

The striking change is in the financing verbs. In June, banks committed to lend Rocket Lab up to US$3.6 billion through a 364-day secured bridge. On 15 September, Rocket Lab reported that the commitment had been formally terminated. By then it had sold approximately 29.3 million new shares in an at-the-market programme for about US$1.944 billion before selling costs. The equity sale is an accomplished transaction. The bridge was a promise of credit, not evidence that US$3.6 billion had been drawn and repaid. Rocket Lab's 8-K makes both distinctions explicit.

A third number is often placed beside those two as though it were another pile of acquisition cash. Iridium had US$1.775 billion of term loans outstanding at 30 June. The borrower remains Iridium Satellite LLC. The 15 September amendment changes the credit agreement so the proposed Rocket Lab takeover does not count as a prohibited change of control, and the lenders expressly consent. The debt is permitted to remain outstanding after closing; it has not become new cash paid to Rocket Lab, nor has it vanished. The funding package therefore replaces a planned refinancing route with the continued service of an existing creditor claim. Iridium's filing describes the borrower and amendment.

The arithmetic needs its labels. US$1.944 billion is gross issuance proceeds, while the bridge-reduction mechanism uses net equity proceeds. The US$1.775 billion is outstanding debt that the buyer need not refinance at closing if the transaction goes through. Rocket Lab says net ATM cash, that amended credit and other available cash or funding cover the anticipated acquisition cash payments, repayment of certain Iridium debt other than the retained loan, and expenses. The filings do not provide a complete closing-date sources-and-uses table. Adding the two headline numbers, US$3.719 billion, would mix cash raised with debt preserved and mistake it for a cash balance.

There is a cost to the lender permission. The consent agreement sets a 0.50% fee on outstanding term loans at consent effectiveness. It also separates the 15 September consent date from the later acquisition-effective date. Rocket Lab USA's downstream guarantee is to be delivered at closing. Only after closing would the amended interest margin apply, with a SOFR spread of 2.50%–3.00% or a base-rate spread of 1.50%–2.00%, according to ratings. A 1% exit fee on applicable prepayments after the first anniversary, and a distinct 1% repricing premium in defined circumstances, are likewise future economics. They are not proof that the higher spread or guarantee was already running on 15 September.

That leaves the fourth ledger: corporate control. Iridium lists a special shareholder meeting for 24 September, and the companies continue to target a mid-2027 closing subject to regulatory approvals and other conditions. The ATM shares remain outstanding even if the merger fails; Rocket Lab says unused net proceeds may then support growth, acquisitions or general corporate purposes. Financing availability can remove a funding obstacle while leaving the owners, network and operating licences where they are. The transaction is funded in management's account of expected payments; it is not closed.